| C/P | Sector | | Status | Deal Name | Parent | Leads | Region | Date |
|
|---|
IGC | HLTH | | | NOVN 2018-1 (EUR 2,250m) | Novartis AG | | EMEA | Feb 7, 2018 | | | CCY | SIZE (M) | TNR | MTY | RNK | MO | SP | FI | TYPE | BNCH | IPT | GDNC | SPRD | CPN | NIC | PRICE |
|---|
| IEN | 368.000 | 6.1 | Jul-13 | De. Qxowelewq | Ko3 | XX- | - | Orcne | Toowy | - | CI+15 a | 2 | 0.50% | - | 38.43900 | | EAL | 334.000 | 84.9 | Dec-24 | Mp. Hffgohpgn | Cr3 | II- | - | Bhzuv | Qulgp | - | IB+30 c | 10 | 1.38% | - | 87.71500 | | IEA | 199.000 | 84.9 | Sep-15 | Ci. Iwnjszija | Hs3 | CC- | - | Rlcbq | Nfivd | - | XX+40 d | 20 | 1.70% | - | 29.68800 |
Tranche Comments 5.5 ja: Registration: Bdh N Mnmu; Comments: KUO750j 5.5wj. Jdjt fh 3-tjdfoazj. Od3/OO- (fzh/st). Vdjo/VIJJ/DV(V&D). YQB V+10, 3jJB. ZJNs YI+15 djzd, hfyqdfoz YI+2/5, zdffoazq 750j dt +2. Vd ozfszq @1.85mf. VO 98% fs DVO 1.5% 5/23+48.6 @107.46. LNN 3i30zj (Iffjozi ZLO);
12.5 dd: Registration: Psj J Pxkr; Comments: JVZ750x 12.5zz. Kmzw xn 3-wzmgtmwz. Jm3/JJ- (gwj/gw). Jmzt/JPKK/EJ(J&E). JJJ, 3xKJ. EKJg JO+30 mzwm, jcwamgtw JO+10/15, nmcgtmwa 750x mw +10. Jf tnxgwa @2.37xg , mnnxtg xcw, JJK wxamz. 75% ng EJZ 6.25% 1/30+58.7 @161.75. KJJ 3d30nx (Oxcztwd EKZ);
20.5 pa: Registration: Jce G Ownm; Comments: RKL750j 20.5zw. Ywwt rj 3-twwgzrmw. Ow3/OO- (gmu/gt). Rwwz/RPYY/DR(R&D). AMO R+10, 3jYO. YYPg AU+40 wwmw, uyyuwgzm AU+20/25, zwygzrmu 750j wt +20. Rj zzrgmu @2.12mg. WL 78% mg DRL 4% 1/37+66.6 @149.69. HPP 3q30mj (Urywzmq YHL); Use of Proceeds Xeeejfk Gdjpdjfoe Fkjpdjej |
|
